XML 34 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue
 12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
REVENUE

14. REVENUE

 

We primarily offer the First Defense® product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the years ended December 31, 2020 and 2019. We do not have any contract assets for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our balance sheets are from contracts with customers. We incur no material costs to obtain contracts.

 

   During the Years Ended December 31, 
   2020   %   2019   % 
United States  $13,644,768    89%  $12,191,108    89%
Other(1)   1,697,436    11%   1,531,764    11%
Total product sales  $15,342,204    100%  $13,722,872    100%

 

The following table presents our product sales disaggregated by geographic area: 

 

(1)Sales outside of the United States included $133,601 of non-animal health sales during the first quarter of 2019, which product has since been divested.

 

The following table presents our product sales disaggregated by major product category:

 

   During the Years Ended December 31, 
   2020   %   2019   % 
First Defense® product line  $15,072,446    98%  $13,244,396    97%
Other animal health   269,758    2%   344,875    2%
Other   —    —    133,601    1%
Total product sales  $15,342,204    100%  $13,722,872    100%